Literature DB >> 26110455

[Discussing Fertility and the Desire to have a Child in Hemato-Oncology--A Qualitative Survey].

Dorit Buske1, Annekathrin Sender2, Diana Richter2, Elmar Brähler2, Kristina Geue2.   

Abstract

OBJECTIVES: Adolescent and young adult patients in hemato-oncology have often not fulfilled their desire to have a child, which is threatened by the malignancy and it's treatment. The oncologists have to inform their patients about possible infertility and fertility preservation.
METHODS: 25 oncologists were interviewed to discuss the desire to have a child and fertility issues with the patients. Afterwards the semi-structured interviews were transcribed and analyzed according to the qualitative content analysis of Mayring.
RESULTS: The following issues could be identified in the interviews: current desire to have a child; possible threat of fertility; fertility preservation and their implementation; contact to a reproduction facility; sexuality and contraception during therapy. Most of the oncologists (n=19) stated to discuss the fertility aspects in the first session. 14 oncologists stated that they have enough knowledge about fertility preservation. To improve the conditions for a discussion the oncologists wished to have more information (n=10) or patient leaflets (n=11) about fertility preservation. DISCUSSION: Addressing the desire to have a child and fertility aspects of adolescent and young adult patients in hemato-oncology have already a high priority. Further studies should analyze the discussion from patient perspective and determine patient needs in this regard. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26110455     DOI: 10.1055/s-0035-1548833

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  1 in total

1.  Sexual and fertility-related adverse effects of medicinal treatment for cancer; a national evaluation among medical oncologists.

Authors:  E M Krouwel; Z Kramer; R Gordijn; M P J Nicolai; S Osanto; H Putter; R C M Pelger; H W Elzevier
Journal:  Support Care Cancer       Date:  2022-01-22       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.